Coadministration of 5-hydroxytryptamine1(A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5- hydroxytryptamine1(A) receptors in hypothalamus

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 1, 2000, Pages 296-301

  Serres, Florence ^a,b   Muma, Nancy A ^a   Raap, Daní K ^a,c   Garcia, Francisca ^a   Battaglia, George ^a   Van De Kar, Louis D ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF ALASKA FAIRBANKS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; CORTICOTROPIN; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OXYTOCIN; PROTEIN DERIVATIVE; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG ANTAGONISM; DRUG MECHANISM; HYPOTHALAMUS; MALE; NONHUMAN; OXYTOCIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENOCORTICOTROPIC HORMONE; ANIMALS; FLUOXETINE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HYPOTHALAMUS; MALE; OXYTOCIN; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS;

EID: 0033942987     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 1A receptor: Signaling, desensitization, and gene transcription. Neuropsychopharmacology 14:19-25.
2. Ananth J (1998) Treatment-resistant depression. Psychother Psychosom 67:61-70.
3. Artigas F (1993) 5-HT and antidepressants: New views from microdialysis studies. Trends Pharmacol Sci 14:262.
4. 2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav Brain Res 73:277-280.
5. Bahouth SW (1995) Thyroid hormone regulation of transmembrane signalling in neonatal rat ventricular myocytes by selective alteration of the expression and coupling of G-protein alpha-subunits. Biochem J 307:831-841.
6. Berman RM, Anand A, Cappiello A, Miller HL, Hu XS, Oren DA and Charney DS (1999) The use of pindolol with fluoxetine in the treatment of major depression: Final results from a double-blind, placebo-controlled trial. Biol Psychiatry 45: 1170-1177.
7. Bhamre S, Wang HY and Friedman E (1998) Serotonin-mediated palmitoylation and depalmitoylation of G alpha proteins in rat brain cortical membranes. J Pharmacol Exp Ther 286:1482-1489.
8. Blier P and Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15:217-222.
9. 1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J Biol Chem 270:18691-18699.
10. Cowen PJ (1998) Neuroendocrine challenge tests: What can we learn from them?, in Methods in Neuroendocrinology (Van de Kar LD ed) pp 205-223, CRC Press, Boca Raton, FL.
11. 1A receptor antagonist WAY100635. Eur J Pharmacol 264:95-97.
12. Fuller RW, Snoddy HD, Perry KW, Bymaster FP and Wong DT (1978) Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin - Comparison of fluoxetine and chlorimipramine. Biochem Pharmacol 27:193-198.
13. 1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: Recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol 10: 16-27.
14. Gartside SE, Clifford EM, Cowen PJ and Sharp T (1999) Effects of (-)-tertatolol, (-)-penbutolol and (+/-l-pindolol in combination with paroxetine on presynaptic 5-HT function: An in vivo microdialysis and electrophysiological study. Br J Pharmacol 127:145-152.
15. zα. J Biol Chem 273:26008-26013.
16. 1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. Neuropharmacology 36:461-465.
17. 1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacol Biochem Behav 54:143-147.
18. 1A receptor function in normal subjects on clinical doses of fluoxetine: Blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology 20:628-639.
19. 1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology 105:415-420.
20. 1A agonist 8-OH-DPAT in male rats. Brain Res 630:148-156.
21. 1A receptors. J Pharmacol Exp Ther 282:1581-1590.
22. 1A agonist. J Pharmacol Exp Ther 279:1035-1042.
23. 1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH ACTH release in the rat. Neuroendocrinology 56:797-802.
24. Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F and Grp RTA (1999) A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Arch Gen Psychiatry 56:375-379.
25. i proteins. J Pharmacol Exp Ther 288:98-106.
26. 1A receptor antagonists. Behav Brain Res 73:153-156.
27. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, Gunn RN, Grasby PM and Cowen PJ (2000) Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: Effects of depression and antidepressant treatment. Arch Gen Psychiatry 57:174-180.
28. 1A receptor sensitivity. Psychopharmacology 132:296-302.
29. 1A receptors in vivo. J Neurosci 20:3095-3103.
30. Steel RGD and Torrie JH (1960) Principles and Procedures of Statistics with Special Reference to the Biological Sciences. McGraw-Hill, New York.
31. Vicentic A, Li Q, Battaglia G and Van de Kar LD (1998) WAY-100635 inhibits 8-OH-DPAT stimulated oxytocin, ACTH, and corticosterone, but not prolactin secretion. Eur J Pharmacol 346:261-266.
32. z GTPase-activating protein subfamily. J Biol Chem 273:26014-26025.